The system for providing medical care to children with oncological and oncohematological diseases in Kyrgyzstan is being steadily strengthened. According to the Ministry of Health, the key areas of work include increased state funding, improved diagnostic quality, and the implementation of modern treatment methods.

Increased funding and access to medicines

The increase in budget funds is aimed at expanding treatment capabilities, ensuring patients receive necessary medications (including anti-tumor drugs), and implementing high-tech medical care. According to the agency, support within the High-Tech Assistance Fund is showing significant growth.

Dynamics of support through the High-Tech Assistance Fund

10 millionsom (initial volume)
20 millionsom (intermediate volume)
100 millionsom (previous stage)
200 millionsom (2025 plan)

New diagnostic capabilities

An immunophenotyping laboratory has been created for in-depth patient research. This method allows for detailed analysis of blood or bone marrow cells (specifically lymphocytes) using special proteins—CD markers. Such studies are essential for accurate diagnosis of hematological and autoimmune diseases, as well as for assessing immune status.

Medical assistance for children with oncological diseases is provided at the National Center for Mother and Child Protection in Bishkek, as well as in the city of Osh.

Context

Specialized assistance is concentrated in two of the country's major cities: Bishkek, where the National Center for Mother and Child Protection is located, and Osh.